NCT00018382
Completed
Phase 2
Insulin, Neurogenetics and Memory in Alzheimer's Disease: A Novel Therapeutic Approach
ConditionsAlzheimer Disease
Drugsrosiglitazone
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Alzheimer Disease
- Sponsor
- US Department of Veterans Affairs
- Locations
- 1
- Status
- Completed
- Last Updated
- 17 years ago
Overview
Brief Summary
This study examines the use of insulin-sensitizing compounds, as therapeutic agents for cognitive impairment in Alzheimer's disease.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 1
Memory and Insulin in Early Alzheimer's DiseaseAlzheimer's DiseaseNCT00581867Jeff Burns, MD31
Completed
Not Applicable
Mechanisms of Insulin Facilitation of MemoryMemory DisordersNCT01145482University of Texas at Austin12
Recruiting
Not Applicable
Brain Insulin Resistance in Mild Cognitive ImpairmentAlzheimer DiseaseMild Cognitive ImpairmentPositron Emission TomographyNCT06116188Turku University Hospital40
Completed
Phase 4
Insulin Resistance and Central Nervous System (CNS) Function in Type 2 DiabetesInsulin ResistanceType 2 Diabetes MellitusNCT00212290National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)140
Withdrawn
Not Applicable
Investigating Brain Insulin Resistance in Alzheimer Disease with IntraNasal Insulin : a Multimodal Neuroimaging StudyAlzheimer DiseaseMild Cognitive ImpairmentNCT06391853Erasme University Hospital120